北京招聘

1.      As a member of Cell line& PD team, he or she can independently do Cell line development with high expression level including clone screening and shake flask cell culture, Amber15/Amber250/3L bioreactor cell culture.

2.       Participate in IND/NDA related upstream documents preparation, review and revision

3.      Be responsible for GS system CHO-K1 cell line development, transfection, high throughput screening technology such as single cell printer, Amber 15/250 and 3L bioreactors.

4.      Participate in upstream process development team together.

Other tasks such as lab management, equipment maintenance etc.

 

Requirements:

1）Master or Ph.D in biology, pharmacy, etc.

2）Have experiences (at least 5 years for Master, 3 years for Ph.D) in cell line development and  culture process development for monoclonal antibody or bispecifics.  A candidate with strong bioreactor operation skills is highly preferred.

3）Work conscientiously and responsibly, with good professional quality and team spirit;

4）Good listening, speaking, reading and writing skills of English.

Zai Lab is an innovative biopharmaceutical company based in Zhang Jiang, Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Zai Lab focus on innovation to meets the unmet medical needs. Zai has built up a strong pipeline with multiple programs on clinical stages. Zai Lab successfully listed on Nasdaq in Sep. 2017.

再鼎医药是一家总部设立于上海张江，致力于研究、开发和销售创新药物的制药企业。再鼎医药针对目前尚无良好治疗手段的疾病领域开发新药，在肿瘤、抗感染、自身免疫等方面建立了全面的产品线，服务中国和全球病患。再鼎医药于2017年9月在美国纳斯达克成功上市。